MDR doesn't appear to be your traditional tech play. The Hospital and Medication industries are so highly regulated its creating governance lead times in years, not weeks like a traditional tech story. Then there is the roll out and acceptance lead times to boot before additional capital will be required to fund the expansion.
it's telling they appear to have abandoned Australian growth for overseas expansion. US needs to be a success now and with $4m cash how do you grow in the worlds biggest market without raising.
so much still has to be achieved before this is product ready.
finally, why has PDX been abandoned with no update, seems to have been a nothing agreement. Adheris is certainly interesting but its unclear how revenues will be split between existing and new customers. It's hard to believe adheris will allow MDR to take away their revenues, so with no information to work with it leaves so many unanswered questions.
EBOS Hospitals? They were announced once upon a time.
- Forums
- ASX - By Stock
- MDR Charting
MDR doesn't appear to be your traditional tech play. The...
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $135.0M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 24.5¢ | $95.88K | 377.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 75628 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 60233 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 55428 | 0.245 |
6 | 74377 | 0.240 |
4 | 383871 | 0.235 |
6 | 60927 | 0.230 |
4 | 95159 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 60233 | 3 |
0.255 | 6200 | 2 |
0.265 | 51353 | 2 |
0.275 | 10000 | 1 |
0.280 | 41000 | 2 |
Last trade - 11.15am 13/11/2024 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online